Cargando…
Placebo response in trials with patients with anxiety, obsessive-compulsive and stress disorders across the lifespan: a three-level meta-analysis
QUESTION: Randomised controlled trials assessing treatments for anxiety, obsessive-compulsive and stress-related disorders often present high placebo response rates in placebo groups. Understanding the placebo response is essential in accurately estimating the benefits of pharmacological agents; nev...
Autores principales: | Motta, Luis Souza, Gosmann, Natan Pereira, Costa, Marianna de Abreu, Jaeger, Marianna de Barros, Frozi, Júlia, Grevet, Laura Tietzmann, Spanemberg, Lucas, Manfro, Gisele Gus, Cuijpers, Pim, Pine, Daniel Samuel, Salum, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163479/ https://www.ncbi.nlm.nih.gov/pubmed/37142305 http://dx.doi.org/10.1136/bmjment-2022-300630 |
Ejemplares similares
-
Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021) -
Generalized anxiety disorder: advances in neuroimaging studies
por: Costa, Marianna de Abreu, et al.
Publicado: (2019) -
Habituating to pandemic anxiety: Temporal trends of COVID-19 anxiety over sixteen months of COVID-19
por: Costa, Marianna de Abreu, et al.
Publicado: (2022) -
Emotional eating in women with generalized anxiety disorder
por: da Fonseca, Natasha Kim de Oliveira, et al.
Publicado: (2023) -
Is the 9-item Patient Health Questionnaire sufficiently sensitive to detect clinical risk of suicide in essential workers seeking emotional support during the COVID-19 pandemic?
por: Motta, Luis Souza, et al.
Publicado: (2022)